| 000 | 01601 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517143500.0 | ||
| 264 | 0 | _c20171116 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1473-5741 | ||
| 024 | 7 |
_a10.1097/CAD.0000000000000466 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMao, Hongwu | |
| 245 | 0 | 0 |
_aNitroxoline shows antimyeloma activity by targeting the TRIM25/p53 axle. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _c04 2017 |
||
| 300 |
_a376-383 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aA549 Cells |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aNitroquinolines _xpharmacology |
| 650 | 0 | 4 | _aOff-Label Use |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aTranscription Factors _xbiosynthesis |
| 650 | 0 | 4 |
_aTripartite Motif Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 |
_aUbiquitin-Protein Ligases _xbiosynthesis |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aDu, Yanyun | |
| 700 | 1 | _aZhang, Zubin | |
| 700 | 1 | _aCao, Biyin | |
| 700 | 1 | _aZhao, Jun | |
| 700 | 1 | _aZhou, Haibin | |
| 700 | 1 | _aMao, Xinliang | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 28 _gno. 4 _gp. 376-383 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0000000000000466 _zAvailable from publisher's website |
| 999 |
_c26975686 _d26975686 |
||